XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Net sales $ 4,370,086 $ 4,525,284 $ 12,285,839 $ 13,242,344
Cost of goods sold 2,842,020 3,020,051 8,079,108 8,861,609
Gross profit 1,528,066 1,505,233 4,206,731 4,380,735
Operating expenses:        
Selling, administrative and other expenses 1,140,156 1,175,699 3,254,442 3,414,414
Depreciation and amortization 69,097 65,667 203,084 186,968
Provision for doubtful accounts 5,633 1,192 23,452 10,430
Restructuring costs 10,968 0 39,009 0
Goodwill impairment charge 0 0 506,721 0
Total operating expenses 1,225,854 1,242,558 4,026,708 3,611,812
Non-operating expenses (income):        
Interest expense 25,788 26,451 72,218 73,567
Other (21,241) (47,655) (46,017) (62,737)
Total non-operating expenses (income) 4,547 (21,204) 26,201 10,830
Income before income taxes 297,665 283,879 153,822 758,093
Income taxes 64,747 71,623 162,059 190,634
Net income (loss) from continuing operations 232,918 212,256 (8,237) 567,459
Net (loss) income from discontinued operations (5,387) 15,231 (192,069) 44,708
Net (loss) income $ 227,531 $ 227,487 $ (200,306) $ 612,167
Dividends declared per common share (usd per share) $ 0.7900 $ 0.7625 $ 2.3700 $ 2.2875
Basic earnings (loss) per share:        
Continuing operations (in dollars per share) 1.61 1.46 (0.06) 3.89
Discontinued operations (in dollars per share) (0.03) 0.10 (1.33) 0.31
Basic earnings (loss) per share (in dollars per share) 1.58 1.56 (1.39) 4.20
Diluted earnings (loss) per share:        
Continuing operations (in dollars per share) 1.61 1.45 (0.06) 3.87
Discontinued operations (in dollars per share) (0.04) 0.11 (1.33) 0.31
Diluted earnings (loss) per share (in dollars per share) $ 1.57 $ 1.56 $ (1.39) $ 4.18
Weighted average common shares outstanding (in shares) 144,273 145,572 144,528 145,875
Dilutive effect of stock options and non-vested restricted stock awards (in shares) 762 617 0 654
Weighted average common shares outstanding - assuming dilution (in shares) 145,035 146,189 144,528 146,529